🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
RATIONALE: Fosaprepitant dimeglumine, palonosetron hydrochloride, and dexam...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2009-02
Trial ID
NCT00895245
This study will assess the bioequivalence of single oral doses of aprepitan...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00945321
This randomized phase III trial studies how well olanzapine with or without...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-11-20
Trial ID
NCT03578081
The purpose of this study is to evaluate the safety and tolerability of a 3...
Status
Completed
Location
Phoenix Childrens Hospital ( Site 1101)
Start Date
2019-09-09
Trial ID
NCT04054193
Treatments Being Tested
This study will assess the efficacy of a single dose of intravenous (IV) fo...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-25
Trial ID
NCT01405924
Treatments Being Tested
This clinical trial studies how well fosaprepitant dimeglumine and graniset...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2012-09-04
Trial ID
NCT01649258
Treatments Being Tested
The goal of this clinical research study is to learn how different doses of...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-05
Trial ID
NCT01490060
Compared With Fosaprepitant dimeglumine for Injection and Palonosetron Hydr...
Status
Completed
Location
Zhe jiangCancer Hospital
Start Date
2025-01-03
Trial ID
NCT07081256
This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07692451
Treatments Being Tested